23May/14

EU agency recommends against Novartis heart failure drug – Yahoo News


Yahoo News

EU agency recommends against Novartis heart failure drug
Yahoo News
ZURICH (Reuters) – EU health regulators have recommended against approving Novartis’s experimental heart failure drug for the second time this year due to insufficient evidence it improves symptoms, the Swiss drugmaker said in a statement on Friday.
Novartis provides update on EU marketing authorization application for RLX030 MarketWatch

all 14 news articles »

23May/14

SurgiQuest's AirSeal® System Highlighted This Week At Annual AUA Meeting – PR Newswire (press release)

SurgiQuest’s AirSeal® System Highlighted This Week At Annual AUA Meeting
PR Newswire (press release)
… including a Robotic Sacrocolpopexy by Wesley White, MD at the University of Tennessee Medical Center, a Robotic Partial Nephrectomy by Dipen Parekh, MD at the University of Miami Hospital, and a Robotic Ureteral Reimplantation performed by Michael …

23May/14

Novartis provides update on EU marketing authorization application for RLX030 … – MarketWatch


Updated News

Novartis provides update on EU marketing authorization application for RLX030
MarketWatch
(Thomson Reuters ONE via COMTEX) — Novartis International AG / Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely …
The EU’s not impressed with Novartis’ ‘breakthrough’ cardio drug, eitherFierceBiotech

all 19 news articles »

23May/14

Scottish independence would damage research funding, warn medical experts – The Guardian


The Guardian

Scottish independence would damage research funding, warn medical experts
The Guardian
The group of signatories includes Prof James Garden, the Queen’s surgeon in Scotland and a pioneer of liver transplant surgery, Prof Wilson Sibbett, the country’s first chief adviser on science and Prof Jean Beggs, a respected geneticist. Three of the …

and more »